The effect of amphotericin B methyl ester (AME) on human immunodeficiency virus (HIV-1) was examined in vitro in cultures of H9, Molt-3 and human peripheral blood lymphocytes acutely infected with HIV. AME inactivates HIV-1 at non-cytotoxic concentrations ranging from 10–100 μg ml−1, and protects pretreated target cells from the cytopathic effects of the virus. AME inhibits the cell to cell spread of virus, as shown by the blocking of syncytia formation in Molt-3 cells, and the reduction in the level of virus expression in cultured peripheral blood leukocytes from an AIDS patient. These results suggest AME may be an effective chemotherapeutic agent in the treatment of AIDS patients, and, because of its unique mode of action may act cooperatively with other AIDS chemotherapeutics.
References
1.
BlancheT.J.LittleJ.R.ShirleyS.F., and LinchR.G. (1977) Augmentation of murine immune responses by amphotericin B. Cell Immunol33: 180–190.
2.
BonnerD.P.TewariR.P.SolotorovskyM.MechlinskiW., and SchaffnerC.P. (1975) Comparative chemotherapeutic activity of amphotericin B and amphotericin B methyl ester. Antimicrob Agents Chemother7: 724–729.
3.
CrewsF.T.McElhaneyM.R.KlepnerC.A., and LippaA.L. (1988) Lipids are major components of human immunodeficiency virus (HIV). Modification of HIV lipid composition, membrane organization and protein confirmation by AL-721. Drug Dev Res14: 31–44.
4.
DalgleishA.G. (1984) The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus. Nature312: 763.
5.
GalloR.C. (1987) The AIDS Virus. Sci Amer255: 47–56.
6.
HoeprichP.D.FlynnN.M.KawachiM.M.LeeK.K.LawrenceR.M.HeathL.K., and SchaffnerC.P. (1988) Treatment of fungal infections with semisynthetic derivatives of amphotericin B. Proc Natl Acad Sci USA544: 517–544.
7.
KiemG.R.JrSibleyP.L.YoonY.H.KuleszaJ.S.ZaidiI.H.MillerM.M., and PoutsiakaJ.W. (1976) Comparative toxicological studies of amphotericin B methyl ester and amphotericin B in mice, rats and dogs. Antimicrob Agents Chemother10: 687–690.
8.
KlatzmannD. (1984) Selective tropism of lymphadenopathy associated virus (LAV) for the helper/inducer subset of T lymphocytes. Science225: 59.
9.
LittleJ.R.AbeggA., and PlutE. (1983) Relationship between adjuvant and mitogens on amphotericin B methyl ester. Cell Immunol78: 224–235.
10.
MechlinskiW., and SchaffnerC.P. (1972) Polyene macrolide derivatives I. N-Acylation and esterification reactions with amphotericin B. J Antibiotics (Tokyo)25: 256.
11.
PontaniD.R. (1987) Viral immunity, infection and treatment of AIDS. Ph.D. Thesis, Waksman Institute of Microbiology, Rutgers University, USA.
12.
PrakashO. (1988) Use of amphotericin B in the treatment of AIDS patients. Clin Res36: 1.
13.
SarinP.S. (1986) Cellular transformation by human T-lymphotrophic retroviruses. In International Encyclopaedia of Pharmacology and Therapeutics. Vol. 126. GrunbergerD., and GoffS.P. (eds). New York: Pergamon Press, pp. 391–405.
14.
SarinP.S. (1988) Molecular pharmacologic approaches to the treatment of AIDS. Annu Rev Pharmacol28: 411–428.
15.
SarinP.S.TaguchiY.SunD.ThorntonA.GalloR.C., and ObergB. (1985) Inhibition of HTLV-III/LAV replication by Foscarnet. Bioch Pharmacol34: 4075–4079.
16.
SchaffnerC.P. (1984) In Macrolide Antibiotics, Chemistry, Biology, and Practice. OmuraS. (ed.). New York: Academic Press, p. 457.
17.
SchaffnerC.P.PlesciaO.J.PontaniD.SunD.ThorntonA.PandeyR.C., and SarinP.S. (1986) Anti-viral activity of amphotericin B methyl ester: inhibition of HTLV-III replication in cell culture. Bioch Pharmacol35: 4110–4113.
18.
SodroskiJ.GohW.C.RosenC.CampbellK., and HazeltineW.A. (1986) Role of the HTLV-III/LAV envelope in syncytium formation and cytopathicity. Nature322: 470.
19.
StevensN.M.EngleC.G.FisherP.B.MechlinskiW., and SchaffnerC.P. (1975) In vitro anti-herpetic activity of water soluble amphotericin B methyl ester. Arch Virol48: 391.
20.
ZaguryD.BernardJ.LeonardR.CheynoinR.FeldmanM.SarinP.S., and GalloR.C. (1986) Long term culture of HTLV-III infected T cells: a model of the cytopathology of T cell depletion in AIDS. Science231: 850–853.
